NPAS3-regulated astrocyte mitochondrial bioenergetics is required for cognition

Area of Science:

• Neuroscience
• Cell Biology
• Metabolic Research

Background:

• Neuronal PAS domain protein 3 (NPAS3) is a transcription factor highly expressed in astrocytes.
• NPAS3 variants are linked to cognitive dysfunction in neuropsychiatric conditions, but mechanisms are unclear.
• Astrocytes play crucial roles in brain metabolism and neuronal support.

Purpose of the Study:

• To investigate the role of NPAS3 in astrocyte mitochondrial bioenergetics.
• To elucidate the cell type-specific mechanisms linking NPAS3 to cognitive function.
• To explore potential glia-targeting therapeutic strategies for cognitive deficits.

Main Methods:

• Selective deletion of the Npas3 gene in mature mouse astrocytes.
• Analysis of mitochondrial gene expression, oxidative phosphorylation, and lactate production in astrocytes.
• Assessment of neuronal excitability, dendritic spine density, and synaptic transmission in the medial prefrontal cortex (mPFC).
• Behavioral testing using trace fear conditioning and rescue experiments with lactate treatment.

Main Results:

• Npas3 deletion in astrocytes reduced mitochondrial glutamate carrier 2 expression, impairing oxidative phosphorylation and lactate production.
• Astrocyte NPAS3 deficiency led to decreased neuronal excitability, dendritic spine density, and excitatory synaptic transmission in mPFC pyramidal neurons.
• Mice with NPAS3-deficient astrocytes showed impaired trace fear conditioning, which was rescued by lactate administration.

Conclusions:

• NPAS3 is a critical regulator of astrocyte mitochondrial bioenergetics.
• Astrocyte NPAS3-dependent metabolism directly influences neuronal function and cognitive behavior.
• Targeting astrocyte metabolism, such as with lactate, offers a potential therapeutic avenue for cognitive dysfunction in neuropsychiatric diseases.